Achieve Life Sciences (QUIT) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Achieve Life Sciences is the larger company by market cap ($573.2 million vs $480.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QUIT | TKNO |
|---|---|---|
| Share price | $5.56 | $7.63 |
| Market cap | $573.25M | $479.95M |
| 1-day change | -5.28% | -2.30% |
| YTD return | — | +100.79% |
| 1-year return | — | +77.44% |
| 5-year return | — | -63.63% |
| EPS (TTM) | $-1.71 | $-0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $40.52M |
| Revenue growth (YoY) | — | +7.35% |
| Net income (latest FY) | $-54.65M | $-17.26M |
| Gross margin | — | 33.17% |
| Operating margin | — | -41.90% |
| Net margin | — | -42.59% |
| 52-week high | $8.64 | $9.48 |
| 52-week low | $2.62 | $1.91 |
| Distance from 52-week high | -35.65% | -19.51% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +162.23% | +28.83% |
| Average volume | 1.38M | 437.31K |
| Shares outstanding | 103.10M | 62.90M |
| Employees | 28 | 158 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Achieve Life Sciences
QUIT stock →Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 28 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 158 employees
QUIT vs TKNO FAQ
Which is bigger, Achieve Life Sciences or Alpha Teknova?
Achieve Life Sciences (QUIT) is larger, with a market capitalization of $573.25M compared with $479.95M for Alpha Teknova (TKNO).
Are Achieve Life Sciences and Alpha Teknova in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.